« New year, more numbersense | Main | The case for one-dose vaccines is lacking key details »

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Ken

The Lancet paper partly discusses the problem. Part of teh manufacturing process is determining the dose concentration. For the Phase I trial they manufactured the vaccine themselves and the concentration was determined by spectrophotometry. They then used a contractor to manufacture the vaccine and it found that spectrophotometry and qPCR gave different results for the concentration. They went with spectrophotometry. They tested subjects for immune response and found that it was poorer than in the Phase 1, and concluded that there was a problem with teh spectrophotometry. So they switched to qPCR to measure concentration.

I agree with Steven Senn's comment that the difference is likely to be one of those spurious results that happen at times in clinical trials.

Kaiser

Ken: I will be reviewing the Lancet paper soon. My brief read of it is the explanation is not detailed enough. If what you said was true, did they conduct an unblinded analysis while the trial was ongoing? Further, the explanation does not address my question. How did they go backwards and identify which specific subjects got the lower dose? I'll say more after I take in the whole paper.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)

Kaiser Fung. Business analytics and data visualization expert. Author and Speaker.
Visit my website. Follow my Twitter. See my articles at Daily Beast, 538, HBR, Wired.

See my Youtube and Flickr.
Numbers Rule Your World:
Amazon - Barnes&Noble

Numbersense:
Amazon - Barnes&Noble

Search3

  • only in Big Data

Next Events

Jan: 10 NYPL Data Science Careers Talk, New York, NY

Past Events

Aug: 15 NYPL Analytics Resume Review Workshop, New York, NY

Apr: 2 Data Visualization Seminar, Pasadena, CA

Mar: 30 ASA DataFest, New York, NY

See more here

Courses

R Fundamentals, Principal Analytics Prep

Numbersense: Statistical Reasoning in Practice, Principal Analytics Prep

Applied Analytics Frameworks & Methods, Columbia

The Art of Data Visualization, NYU

Signed copies at McNally-Jackson, NYC

Excerpts: Numbersense Ch. 1, 7, 8. NRYW

Junk Charts Blog



Link to junkcharts

Graphics design by Amanda Lee

Community